Two-dimensional (2D) perovskites are increasingly recognized as promising candidate materials for the next generation of ...

It is difficult to sum up, or even rank, 2 1/2 centuries’ worth of medical accomplishments in the U.S. While some might think of cutting-edge, snazzy technological achievements, James Gutierrez, MD, ...

The development of cancer is not a process triggered immediately by the emergence of an oncogenic mutation. There is growing ...

A glass of water may look perfectly uniform, but at the molecular level, it could be carrying two different forms that are ...

Research into the biophysical and molecular interactions between aggregation-prone proteins and cellular membranes is a dynamic and expanding field, given ...

In this interview, AZoLife Sciences speaks with Boyd Butler, a microscopy and high-content screening expert at Molecular ...

A new study from the Knight Initiative for Brain Resilience researchers may help explain an enduring mystery about ...

aDepartment of Radiology, Guangdong Provincial People’s Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, China bDepartment of Pathology, Nanfang Hospital, ...

Drug repurposing seeks new therapeutic uses for compounds that already have established safety and pharmacokinetic profiles. Because de novo drug development remains slow, expensive, and prone to ...

The model, Muse Spark, performed better than Meta’s previous A.I. models but lags rivals on coding ability. By Eli Tan Reporting from San Francisco Meta on Wednesday unveiled a new flagship artificial ...

Add Futurism (opens in a new tab) More information Adding us as a Preferred Source in Google by using this link indicates that you would like to see more of our content in Google News results. As ...

HER2CLIMB-05: A Phase III Study of Tucatinib Versus Placebo in Combination With Trastuzumab and Pertuzumab as First-Line Maintenance Therapy for HER2+ Metastatic Breast Cancer Chronic myelomonocytic ...